Eye Concerns
Age Related Eye Disease Study (AREDS)
Finally, there's hope in the fight against age-related macular degeneration and vision loss.
Age-Related Eye Disease Study (AREDS)
A 10-year clinical Age-Related Eye Disease Study (AREDS) by the National Eye Institute reports that there is a unique vitamin and mineral supplement clinically proven to slow the progression of age-related macular degeneration and its associated vision loss among patients most at risk.
The National Eye Institute (a division of the National Institutes of Health) completed a 10-year clinical study which monitored the effects of a high-potency antioxidant vitamin and mineral supplement on age-related macular degeneration.
This double-masked, placebo-controlled clinical study including 3,609 people ages 55 to 80, was conducted to evaluate the effectiveness of a high-potency vitamin and mineral supplement on the preservation of eye health and vision. Its findings clearly prove that a unique high-potency supplement of antioxidant vitamins and zinc can actually slow the progression of moderate to advanced AMD and its associated vision loss.
In fact, when taking this supplement, those most at risk for developing advanced AMD significantly decreased that risk by about 25% and also reduced the risk of vision loss caused by advanced AMD, by about 19%.
PreserVision® Soft Gels are based on the AREDS formula, the one and only antioxidant vitamin and mineral supplement proven clinically effective in the Age-Related Eye Disease Study (AREDS). Easy to swallow, 2 per day soft gels.
Bausch & Lomb PreserVision® Eye Vitamin and Mineral Supplement easy to swallow, 2 per day soft gels.
